Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adipose Tissue (Phase 2)
Alopecia (Phase 4)
Amyotrophic Lateral Sclerosis (Phase 2)
Anemia, Aplastic (Phase 2)
Arthritis, Rheumatoid (Phase 1/Phase 2)
Back Pain (Phase 2)
Cardiomyopathies (Phase 2)
Cartilage Diseases (Phase 2)
Cerebral Palsy (Phase 1)
Chronic Limb-Threatening Ischemia (Phase 2)
Cicatrix (Phase 1/Phase 2)
Colitis, Ulcerative (Phase 2)
Conjunctivitis (Phase 1)
Corneal Diseases (Phase 1/Phase 2)
Corneal Dystrophies, Hereditary (Phase 1/Phase 2)
Corneal Ulcer (Phase 1/Phase 2)
Coronavirus Infections (Phase 2)
COVID-19 (Phase 2/Phase 3)
Crohn Disease (Phase 3)
Cutis Laxa (Phase 1/Phase 2)
Cytokines (Phase 1)
Deficiency Diseases (Phase 1)
Diabetes Mellitus (Phase 1)
Diabetes Mellitus, Type 1 (Phase 1)
Diabetes Mellitus, Type 2 (Phase 1)
Diabetic Foot (Phase 2)
Diabetic Nephropathies (Phase 1)
Dry Eye Syndromes (Early Phase 1)
Dystrophin (Phase 1)
Fractures, Bone (Phase 2)
Healthy Aging (Phase 1)
Intervertebral Disc Degeneration (Phase 1)
Keloid (Phase 2)
Liver Cirrhosis (Phase 2)
Long Term Adverse Effects (Phase 1/Phase 2)
Lymphedema (Phase 3)
Medicine, Chinese Traditional (Phase 1/Phase 2)
Mesenchymal Stem Cells (Phase 1/Phase 2)
Mouth (Phase 2)
Myositis, Inclusion Body (Phase 1)
Osteoarthritis (Phase 2)
Osteoarthritis, Hip (Phase 2)
Osteoarthritis, Knee (Phase 2)
Paralysis (Phase 2)
Pharmacokinetics (Phase 2)
Post-Concussion Syndrome (Phase 1)
Psoriasis (Phase 1/Phase 2)
Regenerative Medicine (Phase 1)
Renal Insufficiency (Phase 1)
Renal Insufficiency, Chronic (Phase 1)
Rotator Cuff Injuries (Phase 2)
Safety (Phase 2)
Scleroderma, Systemic (Phase 2)
Skin (Phase 1/Phase 2)
Spinal Cord Injuries (Phase 2)
Tennis Elbow (Phase 2)
Ulcer (Phase 2)
Urinary Incontinence (Phase 1/Phase 2)
Urinary Incontinence, Stress (Phase 2)
Xerostomia (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue